Journey Medical (NASDAQ:DERM) has received FDA approval for its drug Emrosi for the treatment of rosacea.
Emrosi is the brand name for minocycline hydrochloride extended release 40 mg capsules. The product was developed with Dr. Reddy’s Laboratories (NYSE:RDY).
